Official ESCRS | European Society of Cataract & Refractive Surgeons
Belgrade 2018 Meeting Highlights Registration Abstract Submission Exhibition Virtual Exhibition Hotel Information Satellite Programme Visa Letter Application

Posters

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Corneal collagen cross-linking with riboflavin and UV light in combination with other therapeutic methods for treatment of keratoconus

Poster Details


First Author: M.Jankov SERBIA

Co Author(s): V. Jovanovic   L. Nikolic   T. Mrakovic              

Abstract Details

Purpose:

To present and analiyze feasability, efficacy and safety of different treatment combinations for treating keratoconus (KC): corneal collagen crosslinking (CXL) in combination with topography-guided photorefractive keratectomy (tPRK), intracorneal ring segments (ICRS) and phakic IOLs.

Setting:

LaserFocus - Centre for Eye Microsurgery, Belgrade, Serbia

Methods:

Forty-eight eyes of 43 patients with KC stage 1 to 2 were submitted to CXL treatment with 0.1% riboflavinom and UV light. A combination of ICRS, tPRK and phakic IOL was carried out in patients depending on their associated refractive error: tPRK with maximal depth of 50 microns was performed after a 50 microns PTK was used for the patients with lower refractive error, ICRS using a femtosecond laser was applied in patients with higher ametropia associated with significant corneal assymetry, while phakic IOL has been implanted in patients with higher ammetropias and a regular cornea.

Results:

Six months after CXL only, manifest astigmatism (Cyl) has been reduced from -4.38 +/- 2.03 D to -3.94 +/- 2.30 D, and after additional implanation of ICRS furhter downt to -2.62 +/- 1.93 D; maximal corneal curvature (Kmax) has been reduced from 52.47 +/- 4.01 D tp 51.59 +/- 4.01 D after CXL only, and further to 48.31 +/- 3.65 after ICRS. Inverse order combination showed higher synergic flattening effect. After additional tPRK as the third procedure, Kmax was reduced fromĀ 47.80 +/- 3.97 D to 44.69 +/- 3.19 D.

Conclusions:

Combination of CXL with tPRK, ICRS i phakic IOLs can be used with high degree of safety, efficacy and stability in treatment of modreate keratoconus.

Financial Disclosure:

None

Back to Poster listing